Convalescent plasma has been extensively tested during the COVID-19 pandemic as a
transfusion product. Similarly, monoclonal antibodies have been largely administered either …

Pseudomonas aeruginosa (PA) is a multidrug-resistant (MDR) opportunistic pathogen
causing severe hospital-, and community-acquired infections worldwide. Thus, the …

COVID-19 emergency use authorizations and approvals for vaccines were achieved in
record time. However, there remains a need to develop additional safe, effective, easy-to …

Influenza virus contributes substantially to the global human and animal disease burden. To
protect individuals against disease, strategies are needed to minimize the time an individual …

Background: Some viruses cause outbreaks, which require immediate attention.
Neutralizing antibodies could be developed for viral outbreak management. However, the …

Background One of the countries most adversely affected by the COVID-19 outbreak was
Peru. Worldwide scientific knowledge creation has significantly grown because of this …

The continuously emerging SARS-CoV-2 variants pose a great challenge to the efficacy of
current drugs, this necessitates the development of broad-spectrum antiviral drugs. In the …

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is the primary cause of the
Coronavirus disease 2019 (COVID-19) pandemic, which affects millions of people …

Discussion Over the course of human evolution, we have faced major pandemics caused by
both viral and bacterial pathogens. The Spanish flu of 1917 was the most devastating and …

CONCLUSION The global death toll from COVID-19 is now over six million, with estimates of
excess deaths associated with COVID-19 at least double that figure during 2020 and 2021 …